XLO XILIO THERAPEUTICS INC Investor Conferences 8-K Filing 2024 - Annual Meeting Results Xilio Therapeutics held its 2024 annual meeting of stockholders, where Paul J. Clancy and Christina Rossi were elected as Class III directors and Ernst & Young LLP was ratified as the independent registered public accounting firm.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC